M.H. Liang and E.W. Karlson

Prevalence of SLE: Higher or lower ?
Lupus 1995 4: 421-422. [PDF] [References]  

A.L. Herrick, J.A. Rafferty, and G.P. Margison

DNA repair deficiency in systemic lupus erythematosus: cause or consequence of disease and implications for management
Lupus 1995 4: 423-424. [PDF] [References]  

P.H. Schur

Review: Genetics of systemic lupus erythematosus
Lupus 1995 4: 425-437. [PDF] [References]  

M. Abu-Shakra, D. Buskila, M. Lorber, M. Khamashta, D. Alarcon-Segovia, and Y. Shoenfeld

The mosaic of SLE-II: highlights of the fourth international conference on systemic lupus erythematosus—March 1995
Lupus 1995 4: 438-449. [PDF] [References]  

R.G. Lahita

Special report: adjusted lupus prevalence Results of a marketing study by the Lupus Foundation of America
Lupus 1995 4: 450-453. [Abstract] [PDF] [References]  

M.C. Hochberg, D.L. Perlmutter, T.A. Medsger, V. Steen, M.H. Weisman, B. White, and F.M. Wigley

Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA
Lupus 1995 4: 454-456. [Abstract] [PDF] [References]  

J.G. Hanly, C. Hong, E. Zayed, J.V. Jones, and E. Jones

Immunomodulating effects of synchronised plasmapheresis and intravenous bolus cyclophosphamide in systemic lupus erythematosus
Lupus 1995 4: 457-463. [Abstract] [PDF] [References]  

W.M. Williams, N.A. Staines, S. Muller, and D.A. Isenberg

Human T cell responses to autoantibody variable region peptides
Lupus 1995 4: 464-471. [Abstract] [PDF] [References]  

J. Kaburaki, M. Kuwana, M. Yamamoto, S. Kawai, E. Matsuura, and Y. Ikeda

Clinical significance of phospholipid-dependent anti-ß2-glycoprotein I (ß2-GPI) antibodies in systemic lupus erythematosus
Lupus 1995 4: 472-476. [Abstract] [PDF] [References]  

M. Dueymes, J.C. Piette, M. Le Tonquèze, B. Bendaoud, R. Roué, M. Garré, and P. Youinou

Role of ß2-glycoprotein I in the anticardiolipin antibody affinity for phospholipid in autoimmune disease
Lupus 1995 4: 477-481. [Abstract] [PDF] [References]  

A. Juby, P. Davis, T. Genge, and J. McElhaney

Anticardiolipin antibodies in two elderly subpopulations
Lupus 1995 4: 482-485. [Abstract] [PDF] [References]  

C. Biron, N. Lalloyer, J.L. Tonnelot, D. Larget, J.C. Gris, and J.F. Schved

Anticardiolipin antibodies and acute alcoholic intoxication
Lupus 1995 4: 486-490. [Abstract] [PDF] [References]  

P.R.J. Ames, G. Orefice, and V. Brancaccio

Reversal of thrombocytopenia following oral anticoagulation in two patients with primary antiphospholipid syndrome
Lupus 1995 4: 491-493. [Abstract] [PDF] [References]  

J. Vivancos, J. Soler-Carrillo, J. Ara-del Rey, and J. Font

Development of polyarteritis nodosa in the course of inactive systemic lupus erythematosus
Lupus 1995 4: 494-495. [Abstract] [PDF] [References]  

A.M. Abu El-Asrar, H.O. Naddaf, and A. Mitwali

Choroidopathy in a case of systemic lupus erythematosus
Lupus 1995 4: 496-497. [Abstract] [PDF] [References]  

M. Wahren, J.G. Brun, R. Jonsson, and H.-J. Haga

Autoantibodies to calprotectin are not found in patients with systemic lupus erythematosus or other inflammatory rheumatic diseases
Lupus 1995 4: 498. [PDF] [References]  

Erratum
Lupus 1995 4: 499. [PDF]  

Roberto Arinoviche

A message from the President of ILAR
Lupus 1995 4: 507. [PDF]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.